v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
REVENUE:        
Product revenue, net $ 13,544 $ 1,998 $ 20,422 $ 4,427
COSTS AND EXPENSES:        
Cost of sales 703 3,272 2,281 4,215
Research and development 19,417 10,820 37,630 18,256
Selling, general and administrative 35,959 16,202 64,583 26,306
 Total operating expenses 56,079 30,294 104,494 48,777
Operating loss (42,535) (28,296) (84,072) (44,350)
Grant income 600 1,036 600 1,959
Loss on extinguishment of debt (2,092)
Interest income, net 1,432 943 2,778 1,571
Other expense, net (49) (1,955) (52) (2,189)
Net loss available to common stockholders $ (40,552) $ (28,272) $ (80,746) $ (45,101)
Net loss per common share, basic $ (2.44) $ (3.86) $ (5.32) $ (6.80)
Net loss per common share, diluted $ (2.44) $ (3.86) $ (5.32) $ (6.80)
Weighted average common shares outstanding, basic 16,635,254 7,327,257 15,179,268 6,631,111
Weighted average common shares outstanding, diluted 16,635,254 7,327,257 15,179,268 6,631,111